{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T20:51:24Z","timestamp":1773435084296,"version":"3.50.1"},"reference-count":122,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012253","name":"Guangxi University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012253","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jpha.2020.08.012","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T05:03:54Z","timestamp":1598591034000},"page":"546-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches"],"prefix":"10.1016","volume":"10","author":[{"given":"Mubarak A.","family":"Alamri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4832-4250","authenticated-orcid":false,"given":"Muhammad","family":"Tahir ul Qamar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Usman","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safar M.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matheus","family":"Froeyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2020.08.012_bib1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tim.2015.06.003","article-title":"Bat-to-human: spike features determining \u2018host jump\u2019of coronaviruses SARS-CoV, MERS-CoV, and beyond","volume":"23","author":"Lu","year":"2015","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jpha.2020.08.012_bib2","article-title":"Coronavirus disease 2019 assosiated pneumonia in China: current status and future prospects","author":"Ahmed","year":"2020","journal-title":"Preprints"},{"key":"10.1016\/j.jpha.2020.08.012_bib3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.coviro.2011.10.013","article-title":"Mass extinctions, biodiversity and mitochondrial function: are bats \u2018special\u2019as reservoirs for emerging viruses?","volume":"1","author":"Wang","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jpha.2020.08.012_bib4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.coviro.2013.02.002","article-title":"Reservoirs and vectors of emerging viruses","volume":"3","author":"Mackenzie","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jpha.2020.08.012_bib5","series-title":"Consensus document on the epidemiology of severe acute respiratory syndrome (SARS)","year":"2003"},{"key":"10.1016\/j.jpha.2020.08.012_bib6","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.3390\/v2081803","article-title":"Coronavirus genomics and bioinformatics analysis","volume":"2","author":"Woo","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.jpha.2020.08.012_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.coviro.2014.01.010","article-title":"MERS: emergence of a novel human coronavirus","volume":"5","author":"Raj","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.jpha.2020.08.012_bib8","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1401505","article-title":"Evidence for camel-to-human transmission of MERS coronavirus","volume":"370","author":"Azhar","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jpha.2020.08.012_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.7861\/clinmedicine.4-2-152","article-title":"Severe acute respiratory syndrome (SARS): a review","volume":"4","author":"Vijayanand","year":"2004","journal-title":"Clin. Med."},{"key":"10.1016\/j.jpha.2020.08.012_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.18683\/germs.2019.1155","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): a review","volume":"9","author":"Ramadan","year":"2019","journal-title":"Germs"},{"key":"10.1016\/j.jpha.2020.08.012_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1021\/acscentsci.0c00272","article-title":"Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases","volume":"6","author":"Liu","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jpha.2020.08.012_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4014\/jmb.2003.03011","article-title":"Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19)","volume":"30","author":"Ahn","year":"2020","journal-title":"J.\u00a0Microbiol. Biotechnol."},{"key":"10.1016\/j.jpha.2020.08.012_bib13","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1056\/NEJMp2005492","article-title":"Facing Covid-19 in Italy\u2014ethics, logistics, and therapeutics on the epidemic\u2019s front line","volume":"382","author":"Rosenbaum","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jpha.2020.08.012_bib14","first-page":"1824","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review","volume":"323","author":"Sanders","year":"2020","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.jpha.2020.08.012_bib15","doi-asserted-by":"crossref","first-page":"105948","DOI":"10.1016\/j.ijantimicag.2020.105948","article-title":"A\u00a0review of the 2019 Novel Coronavirus (COVID-19) based on current evidence","volume":"55","author":"Wang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jpha.2020.08.012_bib16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.jpha.2020.08.012_bib17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A\u00a0novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jpha.2020.08.012_bib18","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1073\/pnas.0510851103","article-title":"Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme","volume":"103","author":"Ratia","year":"2006","journal-title":"PNAS USA"},{"key":"10.1016\/j.jpha.2020.08.012_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","article-title":"The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds","volume":"115","author":"B\u00e1ez-Santos","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jpha.2020.08.012_bib20","article-title":"Identification of novel human USP2 inhibitor: might involve in SARS-CoV-2 papain-like (PLpro) protease deubiquitination activity","author":"Mirza","year":"2020","journal-title":"Preprints"},{"key":"10.1016\/j.jpha.2020.08.012_bib21","doi-asserted-by":"crossref","first-page":"16119","DOI":"10.1073\/pnas.0805240105","article-title":"A\u00a0noncovalent class of papain-like protease\/deubiquitinase inhibitors blocks SARS virus replication","volume":"105","author":"Ratia","year":"2008","journal-title":"PNAS USA"},{"key":"10.1016\/j.jpha.2020.08.012_bib22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jpha.2020.08.012_bib23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health\u2014the latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jpha.2020.08.012_bib24","article-title":"Structural modeling and conserved epitopes prediction against SARS-COV-2 structural proteins for vaccine development","author":"Tahir ul Qamar","year":"2020","journal-title":"Research Square"},{"key":"10.1016\/j.jpha.2020.08.012_bib25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jama.2020.0757","article-title":"Coronavirus infections\u2014more than just the common cold","volume":"323","author":"Paules","year":"2020","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.jpha.2020.08.012_bib26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in\u00a0vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.jpha.2020.08.012_bib27","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/cbic.202000047","article-title":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV","volume":"21","author":"Liu","year":"2020","journal-title":"Chembiochem"},{"key":"10.1016\/j.jpha.2020.08.012_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-38450-1","article-title":"Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus","volume":"9","author":"Tahir ul Qamar","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2020.08.012_bib29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12967-019-2116-8","article-title":"Epitope-based peptide vaccine design and target site depiction against Middle East Respiratory Syndrome Coronavirus: an immune-informatics study","volume":"17","author":"Tahir Ul Qamar","year":"2019","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.jpha.2020.08.012_bib30","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jpha.2020.04.008","article-title":"Structural elucidation of SARS-CoV-2 vital proteins: computational methods reveal potential drug candidates against Main protease, Nsp12 RNA-dependent RNA polymerase and Nsp13 helicase","volume":"10","author":"Mirza","year":"2020","journal-title":"J.\u00a0Pharm. Anal."},{"key":"10.1016\/j.jpha.2020.08.012_bib31","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.3390\/ijms17111748","article-title":"Integrated computational approach for virtual hit identification against ebola viral proteins VP35 and VP40","volume":"17","author":"Mirza","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2020.08.012_bib32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/CAD.0000000000000727","article-title":"Discovery of selective inhibitors for cyclic AMP response element-binding protein: a combined ligand and structure-based resources pipeline","volume":"30","author":"Muneer","year":"2019","journal-title":"Anti Canc. Drugs"},{"key":"10.1016\/j.jpha.2020.08.012_bib33","doi-asserted-by":"crossref","first-page":"104371","DOI":"10.1016\/j.meegid.2020.104371","article-title":"Discovery of novel Hepatitis C virus inhibitor targeting multiple allosteric sites of NS5B polymerase","volume":"84","author":"Khalid","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.jpha.2020.08.012_bib34","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.saa.2014.10.045","article-title":"The QSAR and docking calculations of fullerene derivatives as HIV-1 protease inhibitors, Spectrochim","volume":"136","author":"Saleh","year":"2015","journal-title":"Acta Part A: Molecular and Biomolecular Spectroscopy"},{"key":"10.1016\/j.jpha.2020.08.012_bib35","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/jmv.25357","article-title":"Perspectives towards antiviral drug discovery against Ebola virus","volume":"91","author":"Mirza","year":"2019","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.jpha.2020.08.012_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-43129-2","article-title":"In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors","volume":"9","author":"Mirza","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2020.08.012_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jmgm.2018.07.010","article-title":"Investigating the molecular mechanism of staphylococcal DNA gyrase inhibitors: a combined ligand-based and structure-based resources pipeline","volume":"85","author":"Durdagi","year":"2018","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.jpha.2020.08.012_bib38","first-page":"2119","article-title":"In-silico identification and evaluation of plant flavonoids as dengue NS2B\/NS3 protease inhibitors using molecular docking and simulation approach","volume":"30","author":"Tahir ul Qamar","year":"2017","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.jpha.2020.08.012_bib39","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.drudis.2012.06.002","article-title":"Recent progress in structure-based anti-influenza drug design","volume":"17","author":"Du","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jpha.2020.08.012_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060579","article-title":"A\u00a0systematic screen of FDA-approved drugs for inhibitors of biological threat agents","volume":"8","author":"Madrid","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jpha.2020.08.012_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17111748","article-title":"Integrated computational approach for virtual hit identification against ebola viral proteins VP35 and VP40","volume":"17","author":"Mirza","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2020.08.012_bib42","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1517\/17460441.2012.714364","article-title":"Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design","volume":"7","author":"Shurtleff","year":"2012","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.jpha.2020.08.012_bib43","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbrc.2016.07.029","article-title":"Drug repurposing of minocycline against dengue virus infection","volume":"478","author":"Leela","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jpha.2020.08.012_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/minf.201200107","article-title":"Evaluation of adamantane derivatives as inhibitors of dengue virus mRNA cap methyltransferase by docking and molecular dynamics simulations","volume":"32","author":"Luzhkov","year":"2013","journal-title":"Mol. Inform."},{"key":"10.1016\/j.jpha.2020.08.012_bib45","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/AAC.01148-08","article-title":"A\u00a0small-molecule dengue virus entry inhibitor","volume":"53","author":"Wang","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpha.2020.08.012_bib46","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1021\/cb800176t","article-title":"Antiviral compounds discovered by virtual screening of Small\u2212 molecule libraries against dengue virus E protein","volume":"3","author":"Zhou","year":"2008","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jpha.2020.08.012_bib47","first-page":"262","article-title":"Potential of plant alkaloids as dengue ns3 protease inhibitors: molecular docking and simulation approach","volume":"9","author":"Parida","year":"2014","journal-title":"Bangladesh J. Pharmacol."},{"key":"10.1016\/j.jpha.2020.08.012_bib48","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3923\/ijp.2016.621.632","article-title":"Discovery of novel dengue NS2B\/NS3 protease inhibitors using pharmacophore modeling and molecular docking based virtual screening of the zinc database","volume":"12","author":"Tahir ul Qamar","year":"2016","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.jpha.2020.08.012_bib49","series-title":"Strategies towards Protease Inhibitors for Emerging Flaviviruses, Dengue and Zika: Control and Antiviral Treatment Strategies","first-page":"175","author":"Nitsche","year":"2018"},{"key":"10.1016\/j.jpha.2020.08.012_bib50","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.antiviral.2017.12.016","article-title":"Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening","volume":"151","author":"Pattnaik","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jpha.2020.08.012_bib51","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1016\/j.bmcl.2010.04.118","article-title":"Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease","volume":"20","author":"Ramajayam","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jpha.2020.08.012_bib52","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ejmech.2017.05.045","article-title":"Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study","volume":"137","author":"Wang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jpha.2020.08.012_bib53","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","article-title":"Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants","volume":"10","author":"Tahir ul Qamar","year":"2020","journal-title":"J.\u00a0Pharm. Anal."},{"key":"10.1016\/j.jpha.2020.08.012_bib54","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1021\/jm0609162","article-title":"Molecular dynamics and free energy studies on the wild-type and double mutant HIV-1 protease complexed with amprenavir and two amprenavir-related inhibitors: mechanism for binding and drug resistance","volume":"50","author":"Hou","year":"2007","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jpha.2020.08.012_bib55","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.antiviral.2016.11.026","article-title":"Exploring the binding mechanism of Heteroaryldihydropyrimidines and Hepatitis B Virus capsid combined 3D-QSAR and molecular dynamics","volume":"137","author":"Tu","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jpha.2020.08.012_bib56","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1080\/07391102.2016.1234416","article-title":"Quercetin derivatives as non-nucleoside inhibitors for dengue polymerase: molecular docking, molecular dynamics simulation, and binding free energy calculation","volume":"35","author":"Anusuya","year":"2017","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jpha.2020.08.012_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-03719-4","article-title":"Exploration of binding and inhibition mechanism of a small molecule inhibitor of influenza virus H1N1 hemagglutinin by molecular dynamics simulation","volume":"7","author":"Guan","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2020.08.012_bib58","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1039\/C4MB00253A","article-title":"An integrated molecular dynamics, principal component analysis and residue interaction network approach reveals the impact of M184V mutation on HIV reverse transcriptase resistance to lamivudine","volume":"10","author":"Bhakat","year":"2014","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.jpha.2020.08.012_bib59","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0006-3495(01)75999-1","article-title":"Molecular dynamics simulations of human rhinovirus and an antiviral compound","volume":"80","author":"Speelman","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.jpha.2020.08.012_bib60","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bbrc.2017.03.070","article-title":"Molecular dynamics simulations of Zika virus NS3 helicase: insights into RNA binding site activity","volume":"492","author":"Mottin","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jpha.2020.08.012_bib61","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.bbrc.2016.11.098","article-title":"Structure of the NS5 methyltransferase from Zika virus and implications in inhibitor design","volume":"492","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jpha.2020.08.012_bib62","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.chemolab.2016.03.015","article-title":"Computational study on the drug resistance mechanism of hepatitis C virus NS5B RNA-dependent RNA polymerase mutants to BMS-791325 by molecular dynamics simulation and binding free energy calculations","volume":"154","author":"Pan","year":"2016","journal-title":"Chemometr. Intell. Lab. Syst."},{"key":"10.1016\/j.jpha.2020.08.012_bib63","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1021\/ci4002102","article-title":"A\u00a0contribution to the drug resistance mechanism of Darunavir, Amprenavir, Indinavir, and Saquinavir complexes with HIV-1 protease due to flap mutation I50V: a systematic MM\u2013PBSA and thermodynamic integration study","volume":"53","author":"Leonis","year":"2013","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jpha.2020.08.012_bib64","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.antiviral.2013.09.006","article-title":"Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations","volume":"100","author":"Pan","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jpha.2020.08.012_bib65","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.cbpa.2007.08.033","article-title":"Virtual screening strategies in drug discovery","volume":"11","author":"McInnes","year":"2007","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jpha.2020.08.012_bib66","series-title":"The Protein Data Bank, Protein Structure","first-page":"394","author":"Berman","year":"2003"},{"key":"10.1016\/j.jpha.2020.08.012_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/msb.2011.75","article-title":"Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega","volume":"7","author":"Sievers","year":"2011","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.jpha.2020.08.012_bib68","first-page":"82","article-title":"Pymol: an open-source molecular graphics tool","volume":"40","author":"DeLano","year":"2002","journal-title":"CCP4 Newslett. Protein Crystallogr."},{"key":"10.1016\/j.jpha.2020.08.012_bib69","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J.\u00a0Cheminf."},{"key":"10.1016\/j.jpha.2020.08.012_bib70","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/nprot.2016.051","article-title":"Computational protein\u2013ligand docking and virtual drug screening with the AutoDock suite","volume":"11","author":"Forli","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jpha.2020.08.012_bib71","series-title":"BIOVIA, Discovery Studio Modeling Environment","author":"Syst\u00e8mes","year":"2016"},{"key":"10.1016\/j.jpha.2020.08.012_bib72","article-title":"Small-Molecule Library Screening by Docking with PyRx","volume":"Vol. 1263","author":"Dallakyan","year":"2015"},{"key":"10.1016\/j.jpha.2020.08.012_bib73","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jlumin.2015.03.025","article-title":"Interaction of \u03b1-cyperone with human serum albumin: determination of the binding site by using Discovery Studio and via spectroscopic methods","volume":"164","author":"Wang","year":"2015","journal-title":"J.\u00a0Lumin."},{"key":"10.1016\/j.jpha.2020.08.012_bib74","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2020.08.012_bib75","first-page":"148","article-title":"Evaluation of blockbuster drugs under the rule-of-five","volume":"65","author":"Gimenez","year":"2010","journal-title":"Pharmazie-Int. J. Pharm. Sci."},{"key":"10.1016\/j.jpha.2020.08.012_bib76","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jpha.2020.08.012_bib77","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","article-title":"Gromacs 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.jpha.2020.08.012_bib78","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1016\/j.arabjc.2020.02.010","article-title":"Pharmacoinformatics and molecular dynamic simulation studies to identify potential small-molecule inhibitors of WNK-SPAK\/OSR1 signaling that mimic the RFQV motifs of WNK kinases","volume":"13","author":"Alamri","year":"2020","journal-title":"Arabian J. Chem."},{"key":"10.1016\/j.jpha.2020.08.012_bib79","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/1471-2105-7-339","article-title":"Tools for integrated sequence-structure analysis with UCSF Chimera","volume":"7","author":"Meng","year":"2006","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.jpha.2020.08.012_bib80","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA. py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.jpha.2020.08.012_bib81","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/biom9040124","article-title":"Inhibition of oncogenic kinases: an in\u00a0vitro validated computational approach identified potential multi-target anticancer compounds","volume":"9","author":"Ikram","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.jpha.2020.08.012_bib82","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/1871527317666180115162422","article-title":"In silico structure-based identification of novel acetylcholinesterase inhibitors against alzheimer\u2019s disease","volume":"17","author":"Iman","year":"2018","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.jpha.2020.08.012_bib83","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jpha.2020.08.012_bib84","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1021\/ci300385h","article-title":"Molecular dynamics investigation on a series of HIV protease inhibitors: assessing the performance of MM-PBSA and MM-GBSA approaches","volume":"52","author":"Srivastava","year":"2012","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jpha.2020.08.012_bib85","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.theochem.2006.02.022","article-title":"Investigating interactions between HIV-1 gp41 and inhibitors by molecular dynamics simulation and MM\u2013PBSA\/GBSA calculations","volume":"766","author":"Tan","year":"2006","journal-title":"J.\u00a0Mol. Struct.: THEOCHEM"},{"key":"10.1016\/j.jpha.2020.08.012_bib86","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jinf.2013.09.029","article-title":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus","volume":"67","author":"Chan","year":"2013","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.jpha.2020.08.012_bib87","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1021\/jm1004489","article-title":"Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, protein\u2212 ligand X-ray structure and biological evaluation","volume":"53","author":"Ghosh","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jpha.2020.08.012_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines8020288","article-title":"Multiepitope-based subunit vaccine design and evaluation against respiratory syncytial virus using reverse vaccinology approach","volume":"8","author":"Tahir ul Qamar","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.jpha.2020.08.012_bib89","first-page":"1","article-title":"Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro","author":"Alamri","year":"2020","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.jpha.2020.08.012_bib90","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1080\/08927022.2017.1416115","article-title":"Free energy simulations for protein ligand binding and stability","volume":"44","author":"El Hage","year":"2018","journal-title":"Mol. Simulat."},{"key":"10.1016\/j.jpha.2020.08.012_bib91","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1021\/acs.jcim.7b00412","article-title":"Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations: a cross-docking study","volume":"57","author":"Liu","year":"2017","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jpha.2020.08.012_bib92","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10822-016-0005-2","article-title":"Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations","volume":"31","author":"Liu","year":"2017","journal-title":"J.\u00a0Comput. Aided Mol. Des."},{"key":"10.1016\/j.jpha.2020.08.012_bib93","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bbrc.2016.01.081","article-title":"Evaluating the stability of pharmacophore features using molecular dynamics simulations","volume":"470","author":"Wieder","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jpha.2020.08.012_bib94","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1039\/C6MB00077K","article-title":"The binding landscape of plasmepsin V and the implications for flap dynamics","volume":"12","author":"McGillewie","year":"2016","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.jpha.2020.08.012_bib95","doi-asserted-by":"crossref","first-page":"14202","DOI":"10.1039\/C4RA16617E","article-title":"Exploring the binding properties of agonists interacting with human TGR5 using structural modeling, molecular docking and dynamics simulations","volume":"5","author":"Sindhu","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.jpha.2020.08.012_bib96","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0022-2836(84)90231-6","article-title":"Solvent accessible surface area and excluded volume in proteins: analytical equations for overlapping spheres and implications for the hydrophobic effect","volume":"178","author":"Richmond","year":"1984","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jpha.2020.08.012_bib97","doi-asserted-by":"crossref","first-page":"22129","DOI":"10.1039\/C6CP03670H","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 6. Capability to predict protein\u2013protein binding free energies and re-rank binding poses generated by protein\u2013protein docking","volume":"18","author":"Chen","year":"2016","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.jpha.2020.08.012_bib98","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1021\/ci5002185","article-title":"A\u00a0computational approach to enzyme design: predicting \u03c9-aminotransferase catalytic activity using docking and MM-GBSA scoring","volume":"54","author":"Sirin","year":"2014","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jpha.2020.08.012_bib99","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.jpha.2020.08.012_bib100","doi-asserted-by":"crossref","first-page":"14450","DOI":"10.1039\/C7CP07623A","article-title":"Assessing the performance of MM\/PBSA and MM\/GBSA methods. 7. Entropy effects on the performance of end-point binding free energy calculation approaches","volume":"20","author":"Sun","year":"2018","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.jpha.2020.08.012_bib101","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.antiviral.2017.12.015","article-title":"Disulfiram can inhibit mers and sars coronavirus papain-like proteases via different modes","volume":"150","author":"Lin","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jpha.2020.08.012_bib102","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/d41573-020-00016-0","article-title":"Therapeutic options for the 2019 novel coronavirus (2019-nCoV)","volume":"19","author":"Li","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpha.2020.08.012_bib103","article-title":"Computational models identify several FDA approved or experimental drugs as putative agents against SARS-CoV-2","author":"Bobrowski","year":"2020","journal-title":"ChemRxiv."},{"key":"10.1016\/j.jpha.2020.08.012_bib104","series-title":"Prediction of Potential Commercially Inhibitors against SARS-CoV-2 by Multi-Task Deep Model","author":"Hu","year":"2020"},{"key":"10.1016\/j.jpha.2020.08.012_bib105","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jinf.2013.09.029","article-title":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus","volume":"67","author":"Chan","year":"2013","journal-title":"J.\u00a0Infect."},{"key":"10.1016\/j.jpha.2020.08.012_bib106","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/infdis\/jiv392","article-title":"Treatment with lopinavir\/ritonavir or interferon-\u03b21b improves outcome of MERS-CoV infection in a nonhuman primate model of common marmoset","volume":"212","author":"Chan","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.jpha.2020.08.012_bib107","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13063-017-2427-0","article-title":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-\u03b21b (MIRACLE trial): study protocol for a randomized controlled trial","volume":"19","author":"Arabi","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.jpha.2020.08.012_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jpha.2020.08.012_bib109","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.jpha.2020.08.012_bib110","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jtbi.2008.07.030","article-title":"Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CLpro inhibitors","volume":"254","author":"Nukoolkarn","year":"2008","journal-title":"J.\u00a0Theor. Biol."},{"key":"10.1016\/j.jpha.2020.08.012_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: systematic review of treatment effects","volume":"3","author":"Stockman","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.jpha.2020.08.012_bib112","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jmv.25729","article-title":"A\u00a0systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus\u2013A possible reference for coronavirus disease-19 treatment option","volume":"92","author":"Yao","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.jpha.2020.08.012_bib113","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","article-title":"Triple combination of interferon beta-1b, lopinavir\u2013ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial","volume":"395","author":"Hung","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jpha.2020.08.012_bib114","article-title":"Targeting the Coronavirus SARS-CoV-2: computational insights into the mechanism of action of the protease inhibitors Lopinavir, Ritonavir, and Nelfinavir","author":"Moro","year":"2020","journal-title":"Research Square"},{"key":"10.1016\/j.jpha.2020.08.012_bib115","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2165\/00003495-200060060-00009","volume":"60","author":"Hurst","year":"2000","journal-title":"Lopinavir, Drugs"},{"key":"10.1016\/j.jpha.2020.08.012_bib116","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1021\/cb500917m","article-title":"Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV","volume":"10","author":"Lee","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jpha.2020.08.012_bib117","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3851\/IMP1767","article-title":"Small molecule pan-dengue and West Nile virus NS3 protease inhibitors","volume":"21","author":"Cregar-Hernandez","year":"2011","journal-title":"Antiviral Chem. Chemother."},{"key":"10.1016\/j.jpha.2020.08.012_bib118","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3851\/IMP3044","article-title":"Evaluation of antiviral drug synergy in an infectious HCV system","volume":"21","author":"Lin","year":"2016","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.jpha.2020.08.012_bib119","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1021\/jm401398x","article-title":"Discovery of ABT-267, a pan-genotypic inhibitor of HCV NS5A","volume":"57","author":"DeGoey","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jpha.2020.08.012_bib120","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1128\/AAC.00399-10","article-title":"PSI-7851, a pronucleotide of \u03b2-D-2\u2032-deoxy-2\u2032-fluoro-2\u2032-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication","volume":"54","author":"Lam","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpha.2020.08.012_bib121","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1021\/jm500335h","article-title":"Discovery of daclatasvir, a pan-genotypic hepatitis C virus NS5A replication complex inhibitor with potent clinical effect","volume":"57","author":"Belema","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jpha.2020.08.012_bib122","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1128\/AAC.01299-07","article-title":"Potent synergistic anti-human immunodeficiency virus (HIV) effects using combinations of the CCR5 inhibitor aplaviroc with other anti-HIV drugs","volume":"52","author":"Nakata","year":"2008","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177920310558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177920310558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:31:52Z","timestamp":1761859912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177920310558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":122,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2095177920310558"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2020.08.012","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2020.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Xi'an Jiaotong University. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}